(Z)-1,4-diamino-2-butene as a vector of boron, fluorine, or iodine for cancer therapy and imaging:: Synthesis and biological evaluation

被引:21
作者
Martin, B
Possémé, F
Le Barbier, C
Carreaux, F
Carboni, B
Seiler, N
Moulinoux, JP
Delcros, JG
机构
[1] Fac Med, CNRS FRE 2261, Grp Rech Therapeut Anticancereuses, F-35043 Rennes, France
[2] Inst Chim, UMR CNRS 6510, F-35042 Rennes, France
关键词
D O I
10.1016/S0968-0896(02)00147-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polyamine vectors are attractive for tumor targeting. We envisaged (Z)-1,4-diamino-2-butene (Z-DAB), an unsaturated analogue of putrescine Lis vector of B-10. F-18 and I-131 for boron neutron capture therapy (BNCT). and tumor imaging by Positron emission tomography or scintigraphy respectively. In the present work, the synthesis and characterization of new derivatives of Z-DAB were reported. Z-DAB was actively transported in cells via the polyamine transport system and converted into the spermidine analogue. (E)-2-iodo-1,4-diamino-2-butene (E-I-DAB) was not taken up by the polyamine transport system and may not be suitable for tumor imaging. In contrast, (Z)-2-{4-(5,5-dimethyl-[1,3,2]dioxaorinan-2-yl)phenyl}methyl-1,4-diamino-2-butene (Z-4-Bbz-DAB) was a substrate of the transport system and allowed significant boron accumulation in 3LL cells. Its potential in BNCT will be evaluated. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2863 / 2871
页数:9
相关论文
共 49 条
[1]   INTRACELLULAR PUTRESCINE AND SPERMIDINE DEPRIVATION INDUCES INCREASED UPTAKE OF THE NATURAL POLYAMINES AND METHYLGLYOXAL BIS(GUANYLHYDRAZONE) [J].
ALHONENHONGISTO, L ;
SEPPANEN, P ;
JANNE, J .
BIOCHEMICAL JOURNAL, 1980, 192 (03) :941-945
[2]  
BACHRACH U, 1981, CANCER RES, V41, P1205
[3]   SPECIFIC DEPLETION OF SPERMIDINE AND SPERMINE IN HTC CELLS TREATED WITH INHIBITORS OF AMINOPROPYLTRANSFERASES [J].
BEPPU, T ;
SHIRAHATA, A ;
TAKAHASHI, N ;
HOSODA, H ;
SAMEJIMA, K .
JOURNAL OF BIOCHEMISTRY, 1995, 117 (02) :339-345
[4]   Boron-containing polyamines as DNA targeting agents for neutron capture therapy of brain tumors: Synthesis and biological evaluation [J].
Cai, JP ;
Soloway, AH ;
Barth, RF ;
Adams, DM ;
Hariharan, JR ;
Wyzlic, IM ;
Radcliffe, K .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (24) :3887-3896
[5]   TUMOR SELECTIVE ENHANCEMENT OF RADIOACTIVITY UPTAKE IN MICE TREATED WITH ALPHA-DIFLUOROMETHYLORNITHINE PRIOR TO ADMINISTRATION OF C-14-LABELED PUTRESCINE [J].
CHANEY, JE ;
KOBAYASHI, K ;
GOTO, R ;
DIGENIS, GA .
LIFE SCIENCES, 1983, 32 (11) :1237-1241
[6]   DIFFERENCE IN PUTRESCINE TRANSPORT IN UNDIFFERENTIATED VERSUS DIFFERENTIATED MOUSE NB-15 NEURO-BLASTOMA CELLS [J].
CHEN, KY ;
RINEHART, CA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 101 (01) :243-249
[7]  
CLARK RB, 1975, J NUCL MED, V16, P337
[8]  
Cohen S.S., 1998, GUIDE POLYAMINES
[9]  
Delcros JG, 1997, ANTI-CANCER DRUG DES, V12, P35
[10]  
FABIANO E, 1987, SYNTHESIS-STUTTGART, P190